FDA Regulations
FDA Regulations
U.S. Food and Drug Administration (FDA) Regulations and Guidance
Click on the following link for the U.S. Food and Drug Administration (FDA) webpage
Guidance documents do not create or confer any rights for or on any person and do not operate to bind FDA or the public. An alternative approach may be used if such approach satisfies the requirements of the applicable statue, regulations, or both.
FDA Pages
Code of Federal Regulations (CFR) Title 21
- 21 CFR 11: Electronic Records; Electronic Signatures
- 21 CFR 50: Protection of Human Subjects, Informed Consent
- 21 CFR 54: Financial Disclosure
- 21 CFR 56: Institutional Review Boards
- 21 CFR 312: Investigational New Drugs
- 21 CFR 314: FDA Approval to Market a New Drug (NDA)
- 21 CFR 600: Biologics, general
- 21 CFR 601: Biologics, licensing
- 21 CFR 812: Investigational Devices
- 21 CFR 814: Medical Devices, Pre-Market-Approval (PMA)
- 21 CFR 860: Medical Devices, Classification Procedures
FDA Guidance and Information Sheets
- FDA Guidance Search Webpage
- FDA Form 1572 Guidance Document
- Informed Consent
- Drugs
- Medical Devices
- Clinical Trials
Research Compliance
Main Menu
- Rowan Research & Innovation
- Division Offices
- Sponsored Programs
- Research Compliance
- Research Integrity
- Responsible Conduct of Research
- Institutional Review Board
- Institutional Animal Care & Use Committee
- Institutional Biosafety Committee
- Conflict of Interest
- Export Controls
- CITI Training
- Contact Us
- Cannabis Marijuana Research
- Technology Commercialization
- Contact Us
- Explore our Research
- Partnerships
- Centers & Institutes
- South Jersey Technology Park
- Find a Researcher
- Academic Research
- NSF CAREER Awards
- NSF Collaborations